Shares of Hikma Pharmaceuticals PLC HIK inched down 0.93% to £18.09 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising ...

Get a Sample Copy of This Report @ The report sheds light on the competitive landscape, segmentation, geographical expansion, revenue, production, and consumption growth of the Saudi Arabia ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

European stocks closed higher on Thursday as an interest rate cut by the Bank of England (BoE), and some encouraging earnings updates and economic data helped ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Fintel reports that on October 30, 2024, EF Hutton initiated coverage of Carisma Therapeutics (NasdaqGM:CARM) with a Buy ...

Global Alcoholic Hepatitis Treatment MarketAccording to a recent analysis by Future Market Insights (FMI), the global ...

The UK was one of the first countries to recognise them as such. The coronavirus pandemic hit Uber’s ride hailing business hard, but by Q4 2020 it had reached pre-pandemic revenue figures. Uber Eats ...